Krystal Biotech Inc (KRYS)
171.42
+4.59
(+2.75%)
USD |
NASDAQ |
May 22, 10:48
Krystal Biotech Price to Book Value: 6.125 for May 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 21, 2024 | 5.961 |
| May 20, 2024 | 5.876 |
| May 17, 2024 | 5.864 |
| May 16, 2024 | 5.852 |
| May 15, 2024 | 5.831 |
| May 14, 2024 | 5.698 |
| May 13, 2024 | 5.532 |
| May 10, 2024 | 5.530 |
| May 09, 2024 | 5.672 |
| May 08, 2024 | 5.634 |
| May 07, 2024 | 5.78 |
| May 06, 2024 | 5.608 |
| May 03, 2024 | 5.756 |
| May 02, 2024 | 5.725 |
| May 01, 2024 | 5.705 |
| April 30, 2024 | 5.471 |
| April 29, 2024 | 5.645 |
| April 26, 2024 | 5.600 |
| April 25, 2024 | 5.557 |
| April 24, 2024 | 5.677 |
| April 23, 2024 | 5.784 |
| April 22, 2024 | 5.613 |
| April 19, 2024 | 5.658 |
| April 18, 2024 | 5.853 |
| April 17, 2024 | 6.055 |
| Date | Value |
|---|---|
| April 16, 2024 | 6.071 |
| April 15, 2024 | 6.059 |
| April 12, 2024 | 6.197 |
| April 11, 2024 | 6.423 |
| April 10, 2024 | 6.271 |
| April 09, 2024 | 6.417 |
| April 08, 2024 | 6.440 |
| April 05, 2024 | 6.426 |
| April 04, 2024 | 6.371 |
| April 03, 2024 | 6.349 |
| April 02, 2024 | 6.315 |
| April 01, 2024 | 6.285 |
| March 31, 2024 | |
| March 28, 2024 | 6.516 |
| March 27, 2024 | 6.489 |
| March 26, 2024 | 6.378 |
| March 25, 2024 | 6.206 |
| March 22, 2024 | 6.079 |
| March 21, 2024 | 6.170 |
| March 20, 2024 | 6.225 |
| March 19, 2024 | 6.068 |
| March 18, 2024 | 6.124 |
| March 15, 2024 | 6.285 |
| March 14, 2024 | 6.244 |
| March 13, 2024 | 6.517 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.169
Minimum
Nov 26 2021
7.328
Maximum
Jun 13 2023
3.983
Average
3.814
Median
Price to Book Value Benchmarks
| Axsome Therapeutics Inc | 25.51 |
| Catalyst Pharmaceuticals Inc | 3.452 |
| EyePoint Pharmaceuticals Inc | 2.430 |
| Madrigal Pharmaceuticals Inc | 6.230 |
| Viking Therapeutics Inc | 7.521 |
Price to Book Value Related Metrics
| PE Ratio | 91.18 |
| Price | 171.42 |
| Earnings Yield | 1.10% |
| Market Cap | 4.895B |